The oncogenic roles of TMPRSS2 may be linked to poor outcomes with COVID-19 as well [52], while the localization of the gene on 21q22.3 could place individuals with Down syndrome at high risk for COVID-19 infection [49]. Here, TMPRSS2 is linked to COVID-19.